In this Pharmafield article, Monique Martin and Doug Niven talk about the gradual but sustained increase in prices of new orphan drugs in Europe.
Monique Martin is Managing Director, Syneos Health Consulting UK.
Doug Niven is Senior Engagement Manager, Pricing and Market Access, Syneos Health Consulting UK.
